FdaApplication
NDA 020393
Identifiers
- fda_app_no: NDA020393
Properties
| Property | Value |
|---|---|
| applicant_name | BOEHRINGER INGELHEIM PHARMACEUTICALS INC |
| application_type | NDA |
| approval_date | 1995-10-20 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ATROVENT | IPRATROPIUM BROMIDE | 0.021MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SPRAY, METERED;NASAL |
1 product